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In the original version of [Table 1](#t1-jmd-19046-e){ref-type="table"} associated with the review article "Modeling α-Synuclein Propagation with Preformed Fibril Injections", the "amount of PFF injected" for the Rey et al. 2018 paper should be "0.8 μg of 5 mg/ml" instead of "8 μg 1 mg/ml". The injection site mentioned in the "amount of PFFs injected" for Breid et al. 2016 paper should be "intraperitoneal" instead of "intramuscular". The "amount of PFFs injected" for the Manfredsson et al. 2018 paper should be "6×5 μl" instead of "5 μg". Additional information on the concentration of PFFs was added for Breid et al. 2016 paper and Durante et al. 2019 paper, being "1 μg/μl" and "1 mg/ml", respectively.

In the first paragraph of the "SYNUCLEINOPATHIES IN PERIPHERAL PFF INJECTION MODELS" section, we included the description olfactory bulb injection. However, this content belongs to the "SYNUCLEINOPATHIES IN INTRACEREBRAL PFF INJECTION MODELS" section.

###### 

Injection methodologies from recent studies

  Author                          Year   Injection site                                Duration/Time point                           Model                                                                                                 Amount of PFFs injected
  ------------------------------- ------ --------------------------------------------- --------------------------------------------- ----------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------
  Luk et al. \[20\]               2012   Somatosensory cortex and dorsal neostriatum   30 and 90 days post injection (p.i)           M83 mice maintained on a C57BL/C3H background, α-syn -/- mice maintained on a C57BL/6 background      5 μg of 5 mg/mL human α-syn^1-120^Myc or WT full-length human α-syn per brain
  Luk et al. \[18\]               2012   Striatum                                      30, 90, and 180 days p.i                      C57BL6/C3H F1, C57BL6/SJL F1, and CD1 mice                                                            5 μg of 5 mg/mL full-length WT mouse α-syn per hemisphere
  Masuda-Suzukake et al. \[40\]   2013   Substantia nigra                              15 months p.i                                 4- to 6-month-old female C57BL/6J mice                                                                10 µg of mouse or human α-syn PFFs
  Guo et al. \[60\]               2013   Hippocampus                                   3, 6, and 9 months p.i                        2- to 3-month-old PS19 mice or C57BL6/C3H F1 mice                                                     5 μg of PFFs
  Sacino et al. \[49\]            2014   Hippocampus                                   1, 2, and 4 months p.i                        2-month-old M83 mice and M20 mice                                                                     2 μL of 2 mg/mL hfib 21--140 or Δ71--82 α-syn
  Sacino et al. \[27\]            2014   Intramuscular (biceps femoris)                4, 8, and 12 months p.i                       2-month-old M83 mice and M20 mice                                                                     10 μg of mouse PFFs, human 21--140 α-syn PFFs or Δ71--82 α-syn
  Paumier et al. \[48\]           2015   Striatum                                      30, 60, and 180 days p.i                      Adult male Sprague-Dawley rats                                                                        8 μg of mouse or human α-syn PFFs
  Osterberg et al. \[39\]         2015   Cortex                                        2, 3, and 4 months p.i                        2- to 3-month-old α-syn-GFP mice                                                                      2.5 µL of 2 mg/mL mouse WT α-syn PFFs
  Peelaerts et al. \[57\]         2015   Substantia nigra                              4 months p.i                                  Female Wistar rats                                                                                    2 µL of 5 µg/µL α-syn PFFs (total of 10 µg)
  Breid et al. \[30\]             2016   Peritoneum, tongue                            Up to 420 days p.i                            Tg (M83+/−:Gfap-luc+/−) and (Gfap-luc+/−) mice                                                        5 μl (intraglossal) or 50 μl (intraperitoneal) of 1 ug/ul sonicated α-syn PFFs
  Kim et al. \[59\]               2016   Striatum                                      3 and 6 months p.i                            3-month-old C57BL/6J mice                                                                             5 μL of 10 μg/μL recombinant α-syn monomer, 2 μg/μL LPS(−) fibril seed, and 2 μg/μL LPS(+) fibril seed
  Thakur et al. \[45\]            2017   Substantia nigra, ventral tegmental area      10 days p.i                                   Female Sprague-Dawley rats                                                                            2.5 μL of full-length recombinant human α-syn PFFs (10 μg total) per site
  Karampetsou, et al. \[21\]      2017   Striatum                                      60 days p.i                                   2- to 4-month-old male and female wild-type C57BL6/C3H mice and α-Syn-/- mice (C57BL6/JOlaHsd mice)   4.25 μg (4 μL) of three different types of human recombinant fibrillar α-syn
  Abdelmotilib et al. \[35\]      2017   Striatum                                      6 months p.i                                  8- to 10-week-old mice and rats                                                                       10 μg (mice) or 20 μg (rats) of mouse or human α-syn PFFs
  Blumenstock et al. \[43\]       2017   Dorsal striatum                               30, 60, and 90 days p.i; 5 and 9 months p.i   2-month-old mice                                                                                      5 μL (25 μg) of mouse α-syn PFFs
  Sorrentino et al. \[56\]        2017   IC or CPu                                     4--5 months p.i                               4-month-old M20 non-Tg (NTG) mice                                                                     2 μL of 2 mg/mL human or mouse WT α-syn PFFs
  Harms et al. \[63\]             2017   Substantia nigra                              1, 3, and 6 months p.i                        8- to 10-week old Sprague-Dawley rats                                                                 8 μg of mouse α-syn PFFs
  Shimozawa et al. \[50\]         2017   Caudate and putamen                           3 months p.i                                  26-month-old marmosets                                                                                50 μL aliquots of 4 mg/mL mouse α-syn PFFs
  Okuzumi et al. \[44\]           2018   Striatum                                      1 week pi, 0.75, 1.5, 3, and 6 months p.i     2- to 3-month-old C57BL/6J mice                                                                       5 μg/2.5 μL of recombinant mouse or human α-syn PFFs
  Rey et al. \[29\]               2018   Olfactory bulb                                1, 2, 3, 6, 9, 12, 18, and 23 months p.i      3-month-old female C57BL/6J mice                                                                      0.8 μl of 5 mg/ml WT mouse or human α-syn PFFs
  Uemura et al. \[28\]            2018   Mouse gastric wall                            45 days p.i                                   2-month-old male C57BL/6J mice                                                                        3 μL of 2 μg/μL mouse α-syn PFFs
  Duffy et al. \[47\]             2018   Striatum                                      6 months p.i                                  2-month-old male Fischer mice                                                                         2 μL of 2 μg/μL mouse α-syn PFFs (unilateral)
  Sorrentino et al. \[42\]        2018   Muscle                                        1, 2, 3, and 4 months p.i                     2-month-old M83+/- mice                                                                               2,5, or 10 μg of mouse α-syn fibrils
  Milanese et al. \[41\]          2018   Striatum                                      4 months p.i                                  C57BL/6 mice                                                                                          5 μg (2.5 μL) of human α-syn PFFs
  Terada et al. \[46\]            2018   Striatum                                      3 months p.i                                  10-week-old C57BL/6J mice                                                                             5 μL (150 μM) of human WT
  Milanese et al. \[41\]          2018   Striatum                                      4 months p.i                                  C57BL/6 mice                                                                                          5 μg (2.5 μL) of human α-syn PFFs
  Terada et al. \[46\]            2018   Striatum                                      3 months p.i                                  10-week-old C57BL/6J mice                                                                             5 μL (150 μM) of human WT or truncated α-syn PFFs
  Ayers et al. \[54\]             2018   Sciatic nerve (unilateral)                    1, 2, and 4 months p.i and end-stage          M83 and M20 mice                                                                                      2 μL of 2 mg/mL mouse WT or human Δ71--82 α-syn PFFs
  Manfredsson et al. \[55\]       2018   Enteric neurons of the descending colon       1, 6, and 12 months p.i                       Young adult male Sprague-Dawley rats                                                                  6×5 µl of 2 μg/μl mouse or human α-syn PFFs
  Manfredsson et al. \[55\]       2018   Colon and stomach                             12 months p.i                                 Non-human primates (Macaca fascicularis)                                                              10 injections of 10 µL (2 µg/µL)
  Peralta Ramos et al. \[68\]     2019   Vein                                          12 hours p.i                                  2-month-old C57BL/6 mice                                                                              5 μg of Atto 488-labeled α-syn fibrils or ribbons
  Durante et al. \[77\]           2019   Striatum                                      6, 7 weeks p.i                                Male Wistar rats                                                                                      1 µL of 1 mg/ml human α-syn PFFs per site

The table describes the sites of preformed fibril (PFF) injection, the ages of the animals, the amount of seed, and the duration or time points sample analysis used in the experiments. WT: wild type, GFP: green fluorescent protein, LPS: lipopolysaccharide, IC: inferior colliculus, CPu: caudate putamen, NTG: non-Tg.
